BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
64.53
-0.97 (-1.48%)
At close: Mar 3, 2026, 4:00 PM EST
64.53
0.00 (0.00%)
After-hours: Mar 3, 2026, 4:05 PM EST
BridgeBio Pharma Market Cap
BridgeBio Pharma has a market cap or net worth of $12.5 billion as of March 3, 2026. Its market cap has increased by 109.58% in one year.
Market Cap
12.50B
Enterprise Value
13.68B
1-Year Change
109.58%
Ranking
Category
Stock Price
$64.53
Market Cap Chart
Since June 27, 2019, BridgeBio Pharma's market cap has increased from $3.32B to $12.50B, an increase of 276.54%. That is a compound annual growth rate of 21.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 12.70B | -13.86% |
| Dec 31, 2025 | 14.74B | 184.24% |
| Dec 31, 2024 | 5.19B | -26.16% |
| Dec 29, 2023 | 7.02B | 516.56% |
| Dec 30, 2022 | 1.14B | -53.61% |
| Dec 31, 2021 | 2.46B | -71.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 27, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ascendis Pharma | 14.86B |
| Ionis Pharmaceuticals | 13.54B |
| Summit Therapeutics | 12.55B |
| Jazz Pharmaceuticals | 11.72B |
| BioMarin Pharmaceutical | 11.49B |
| Avidity Biosciences | 11.30B |
| ImmunityBio | 10.73B |
| Exelixis | 10.66B |